SCHEDULE 13G/A: Vanguard Group Discloses 10.13% Passive Stake in Elevance Health

The Vanguard Group has filed an amended Schedule 13G, reporting a 10.13% beneficial ownership stake in Elevance Health Inc., held for passive investment purposes.

Summary

• The Vanguard Group beneficially owns 22,890,772 shares of Elevance Health Inc. common stock.
• This ownership represents 10.13% of the total class of securities.
• The Vanguard Group holds sole dispositive power over 21,785,156 shares and shared dispositive power over 1,105,616 shares.
• The firm has shared voting power over 288,456 shares and no sole voting power.
• This filing is an Amendment No. 10 to a Schedule 13G, indicating an update to a previously reported beneficial ownership.
• The securities are certified to be acquired and held in the ordinary course of business, without the purpose or effect of changing or influencing the control of Elevance Health Inc.

Sentiment

Score: 5

Explanation: The document is a factual regulatory filing disclosing beneficial ownership and does not convey explicit positive or negative sentiment regarding the issuer's performance or prospects.

Positives

• A major institutional investor, The Vanguard Group, maintains a significant stake in Elevance Health Inc., which can be viewed as a vote of confidence in the company's long-term stability.
• The passive nature of Vanguard's investment indicates no immediate intent to influence corporate control, suggesting stability in the company's governance structure.

Negatives

• The document itself does not present any explicit negative information regarding Elevance Health Inc. or the investment.

Risks

• The filing itself does not detail specific risks related to Elevance Health Inc.'s operations or financial performance.
• As a passive investor, The Vanguard Group does not intend to influence the control of the issuer, which means they may not actively intervene in adverse situations affecting the company.

Future Outlook

The document, a Schedule 13G, does not provide forward-looking statements or guidance regarding Elevance Health Inc.'s future performance or outlook.

Management Comments

• Ashley Grim, Head of Global Fund Administration for The Vanguard Group, certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Elevance Health Inc.

Industry Context

This filing reflects a standard disclosure by a large institutional asset manager, The Vanguard Group, regarding its significant passive investment in Elevance Health Inc., a prominent player in the U.S. healthcare industry. Such large passive stakes are common for major index fund providers and reflect their broad market exposure rather than a specific strategic move related to industry trends.

Comparison to Industry Standards

• This document is a regulatory filing detailing beneficial ownership and does not provide information for comparison to industry standards regarding company performance or operational metrics.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holding in the company.
• Management: Awareness of a large, passive institutional investor holding a substantial stake in the company.

Next Steps

• The document does not outline specific future actions, events, or milestones for Elevance Health Inc. or The Vanguard Group beyond ongoing regulatory compliance.

Key Dates

Keywords

Elevance Health, Vanguard Group, Schedule 13G, beneficial ownership, common stock, institutional investor, healthcare, passive investment